William A. Jones Jr. - 25 Apr 2024 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Commercial Officer
Signature
/s/ William A. Jones, Jr.
Issuer symbol
NAMS
Transactions as of
25 Apr 2024
Net transactions value
$0
Form type
3
Filing time
03 May 2024, 16:15:21 UTC
Previous filing
17 Jul 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAMS Option (right to buy) 25 Apr 2024 Ordinary Shares 815,598 $10.70 Direct F1
holding NAMS Option (right to buy) 25 Apr 2024 Ordinary Shares 130,000 $11.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on August 14, 2023. 25% of the shares underlying the option will vest on the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.
F2 The option was granted on January 1, 2024. 25% of the shares underlying the option will vest on the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney